insights_auto
Mengapa 524494 turun 3,51%?
Pelajari Lebih Lanjutchevron_right
524494:BOM
IPCA Laboratories Ltd
Rs 1.845,00
arrow_downward
-3,51%(-67,20) 1 HR
16 Okt, 15.30.00 GMT+5.30 · INR
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk 524494...
Pembukaan
Rs 1.913,95
Tinggi
Rs 1.913,95
Rendah
Rs 1.812,60
Kapitalisasi pasar
468,21Â M
Volume rata-rata
27,90Â rb
Volume
12,00Â rb
Dividen
0,33%
Dividen per kuartal
Rs 1,50
Tanggal tanpa dividen
7 Agu 2026
Rasio P/E
35,74
Harga tinggi dalam 52 minggu terakhir
Rs 2.039,30
Harga rendah dalam 52 minggu terakhir
Rs 1.252,95
EPS
Rs 51,63
Saham beredar
126,35Â jt
Jumlah karyawan
17Â rb
Pembukaan
Rs 1.913,95
Tinggi
Rs 1.913,95
Rendah
Rs 1.812,60
Kapitalisasi pasar
468,21Â M
Volume rata-rata
27,90Â rb
Volume
12,00Â rb
Dividen
0,33%
Dividen per kuartal
Rs 1,50
Tanggal tanpa dividen
7 Agu 2026
Rasio P/E
35,74
Harga tinggi dalam 52 minggu terakhir
Rs 2.039,30
Harga rendah dalam 52 minggu terakhir
Rs 1.252,95
EPS
Rs 51,63
Saham beredar
126,35Â jt
Jumlah karyawan
17Â rb
Artikel berita
Dari sumber web dan partner berita
Investing.com Indonesia
·
6 jam yang lalu
Mengapa SPDR S&P 500 ETF Trust turun hari ini?
Investing.com Indonesia
·
9 jam yang lalu
IHSG -40%, S&P 500 +22% dalam Rupiah: Panduan Pemula Mulai Investasi Saham AS
XTB.com
·
22 jam yang lalu
Dow Jones Naik 1%, Yield Treasury AS Turun ke 5,1%
XTB.com
·
10 jam yang lalu
Dow Jones Naik, Nasdaq dan Saham AI Turun
Profil
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
Tentang IPCA Laboratories Ltd